| Maggie Woods, MD | |
|
3233 E 2nd St N, Wichita, KS 67208-3202 | |
| (316) 683-6766 | |
| (316) 683-1342 |
| Full Name | Maggie Woods |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 9 Years |
| Location | 3233 E 2nd St N, Wichita, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144601030 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 04-42280 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| College Hill Ob/gyn, P.a. | 0941276307 | 7 |
News Archive
One of the earliest events that changes a normal cell into a malignant one is known as deoxyribonucleic acid (DNA) hypermethylation, a biochemical alteration that inactivates critical tumor-suppressor genes.
New drugs that target specific molecular mechanisms of cancer have improved the treatment of cancer patients in recent years, but those benefits may come with a cost to the patient's sex life, researchers have found.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Jose Esparza, deputy director of vaccines and HIV at the Gates Foundation, reports on AIDS Vaccine 2011, a conference being held this week in Bangkok, Thailand, that is expected to draw more than 800 scientists and policymakers from around the world.
Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma.
› Verified 1 days ago
| Entity Name | College Hill Ob/gyn, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083688980 PECOS PAC ID: 0941276307 Enrollment ID: O20040907001199 |
News Archive
One of the earliest events that changes a normal cell into a malignant one is known as deoxyribonucleic acid (DNA) hypermethylation, a biochemical alteration that inactivates critical tumor-suppressor genes.
New drugs that target specific molecular mechanisms of cancer have improved the treatment of cancer patients in recent years, but those benefits may come with a cost to the patient's sex life, researchers have found.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Jose Esparza, deputy director of vaccines and HIV at the Gates Foundation, reports on AIDS Vaccine 2011, a conference being held this week in Bangkok, Thailand, that is expected to draw more than 800 scientists and policymakers from around the world.
Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma.
› Verified 1 days ago
| Entity Name | Wesley Physicians Medical Specialties Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699069732 PECOS PAC ID: 1355509886 Enrollment ID: O20120229000737 |
News Archive
One of the earliest events that changes a normal cell into a malignant one is known as deoxyribonucleic acid (DNA) hypermethylation, a biochemical alteration that inactivates critical tumor-suppressor genes.
New drugs that target specific molecular mechanisms of cancer have improved the treatment of cancer patients in recent years, but those benefits may come with a cost to the patient's sex life, researchers have found.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Jose Esparza, deputy director of vaccines and HIV at the Gates Foundation, reports on AIDS Vaccine 2011, a conference being held this week in Bangkok, Thailand, that is expected to draw more than 800 scientists and policymakers from around the world.
Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maggie Woods, MD 3233 E 2nd St N, Wichita, KS 67208-3202 Ph: (316) 683-6766 | Maggie Woods, MD 3233 E 2nd St N, Wichita, KS 67208-3202 Ph: (316) 683-6766 |
News Archive
One of the earliest events that changes a normal cell into a malignant one is known as deoxyribonucleic acid (DNA) hypermethylation, a biochemical alteration that inactivates critical tumor-suppressor genes.
New drugs that target specific molecular mechanisms of cancer have improved the treatment of cancer patients in recent years, but those benefits may come with a cost to the patient's sex life, researchers have found.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Jose Esparza, deputy director of vaccines and HIV at the Gates Foundation, reports on AIDS Vaccine 2011, a conference being held this week in Bangkok, Thailand, that is expected to draw more than 800 scientists and policymakers from around the world.
Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma.
› Verified 1 days ago
Damen Wayne Hershberger, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9300 E 29th St N Ste 320, Wichita, KS 67226 Phone: 316-858-7100 Fax: 316-858-7103 | |
Edmond G Feuille Ii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 551 N Hillside St, Ste 510, Wichita, KS 67214 Phone: 316-685-0559 Fax: 316-685-0455 | |
Dr. Elizabeth Carole Melton-mendoza, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-962-3100 | |
Mackenzie Dikeman, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St Ste 3023, Wichita, KS 67214 Phone: 316-293-2665 | |
Lucy Lehoczky, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St Ste 3023, Wichita, KS 67214 Phone: 316-293-2665 | |
Andrea Marie Fullerton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1515 S Clifton, Ste 400, Wichita, KS 67208 Phone: 316-636-1550 Fax: 316-689-9769 | |
Dr. Thalia J Lopez, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 527 N Grove St, Wichita, KS 67214 Phone: 316-262-2415 Fax: 316-264-4734 |